278 related articles for article (PubMed ID: 26461094)
1. Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.
Salanti A; Clausen TM; Agerbæk MØ; Al Nakouzi N; Dahlbäck M; Oo HZ; Lee S; Gustavsson T; Rich JR; Hedberg BJ; Mao Y; Barington L; Pereira MA; LoBello J; Endo M; Fazli L; Soden J; Wang CK; Sander AF; Dagil R; Thrane S; Holst PJ; Meng L; Favero F; Weiss GJ; Nielsen MA; Freeth J; Nielsen TO; Zaia J; Tran NL; Trent J; Babcook JS; Theander TG; Sorensen PH; Daugaard M
Cancer Cell; 2015 Oct; 28(4):500-514. PubMed ID: 26461094
[TBL] [Abstract][Full Text] [Related]
2. The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility.
Spliid CB; Toledo AG; Sanderson P; Mao Y; Gatto F; Gustavsson T; Choudhary S; Saldanha AL; Vogelsang RP; Gögenur I; Theander TG; Leach FE; Amster IJ; Esko JD; Salanti A; Clausen TM
J Biol Chem; 2021 Dec; 297(6):101391. PubMed ID: 34762909
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.
Clausen TM; Pereira MA; Al Nakouzi N; Oo HZ; Agerbæk MØ; Lee S; Ørum-Madsen MS; Kristensen AR; El-Naggar A; Grandgenett PM; Grem JL; Hollingsworth MA; Holst PJ; Theander T; Sorensen PH; Daugaard M; Salanti A
Mol Cancer Res; 2016 Dec; 14(12):1288-1299. PubMed ID: 27655130
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of placental malaria protein VAR2CSA interaction with a chemo-enzymatically synthesized chondroitin sulfate library.
Sugiura N; Clausen TM; Shioiri T; Gustavsson T; Watanabe H; Salanti A
Glycoconj J; 2016 Dec; 33(6):985-994. PubMed ID: 27287227
[TBL] [Abstract][Full Text] [Related]
5. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1.
Ayres Pereira M; Mandel Clausen T; Pehrson C; Mao Y; Resende M; Daugaard M; Riis Kristensen A; Spliid C; Mathiesen L; E Knudsen L; Damm P; G Theander T; R Hansson S; A Nielsen M; Salanti A
PLoS Pathog; 2016 Aug; 12(8):e1005831. PubMed ID: 27556547
[TBL] [Abstract][Full Text] [Related]
6. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
[TBL] [Abstract][Full Text] [Related]
7. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
[TBL] [Abstract][Full Text] [Related]
8. An affinity chromatography and glycoproteomics workflow to profile the chondroitin sulfate proteoglycans that interact with malarial VAR2CSA in the placenta and in cancer.
Toledo AG; Pihl J; Spliid CB; Persson A; Nilsson J; Pereira MA; Gustavsson T; Choudhary S; Oo HZ; Black PC; Daugaard M; Esko JD; Larson G; Salanti A; Clausen TM
Glycobiology; 2020 Dec; 30(12):989-1002. PubMed ID: 32337544
[TBL] [Abstract][Full Text] [Related]
9. Malaria Biomimetic for Tumor Targeted Drug Delivery.
Pihl J; Clausen TM; Zhou J; Krishnan N; Ørum-Madsen MS; Gustavsson T; Dagil R; Daugaard M; Choudhary S; Foged C; Esko JD; Zhang L; Fang RH; Salanti A
ACS Nano; 2023 Jul; 17(14):13500-13509. PubMed ID: 37435892
[TBL] [Abstract][Full Text] [Related]
10. Fighting Cancer Using an Oncofetal Glycosaminoglycan-Binding Protein from Malaria Parasites.
Agerbæk MØ; Bang-Christensen S; Salanti A
Trends Parasitol; 2019 Mar; 35(3):178-181. PubMed ID: 30551869
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into chondroitin sulfate binding in pregnancy-associated malaria.
Khunrae P; Higgins MK
Biochem Soc Trans; 2010 Oct; 38(5):1337-41. PubMed ID: 20863310
[TBL] [Abstract][Full Text] [Related]
12. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A.
Bigey P; Gnidehou S; Doritchamou J; Quiviger M; Viwami F; Couturier A; Salanti A; Nielsen MA; Scherman D; Deloron P; Tuikue Ndam N
J Infect Dis; 2011 Oct; 204(7):1125-33. PubMed ID: 21881129
[TBL] [Abstract][Full Text] [Related]
13. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum.
Duffy MF; Maier AG; Byrne TJ; Marty AJ; Elliott SR; O'Neill MT; Payne PD; Rogerson SJ; Cowman AF; Crabb BS; Brown GV
Mol Biochem Parasitol; 2006 Aug; 148(2):117-24. PubMed ID: 16631964
[TBL] [Abstract][Full Text] [Related]
14. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
[TBL] [Abstract][Full Text] [Related]
15. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
[TBL] [Abstract][Full Text] [Related]
16. Platelet Membrane-Coated and VAR2CSA Malaria Protein-Functionalized Nanoparticles for Targeted Treatment of Primary and Metastatic Cancer.
Zhou M; Lai W; Li G; Wang F; Liu W; Liao J; Yang H; Liu Y; Zhang Q; Tang Q; Hu C; Huang J; Zhang R
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25635-25648. PubMed ID: 34038097
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration.
Dahlbäck M; Rask TS; Andersen PH; Nielsen MA; Ndam NT; Resende M; Turner L; Deloron P; Hviid L; Lund O; Pedersen AG; Theander TG; Salanti A
PLoS Pathog; 2006 Nov; 2(11):e124. PubMed ID: 17112315
[TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
19. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
